Analyzing Ratios: Ideaya Biosciences Inc (IDYA)’s Financial Story Unveiled

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Ideaya Biosciences Inc (NASDAQ: IDYA) closed at $30.54 in the last session, down -0.49% from day before closing price of $30.69. In other words, the price has decreased by -$0.49 from its previous closing price. On the day, 0.79 million shares were traded. IDYA stock price reached its highest trading level at $31.41 during the session, while it also had its lowest trading level at $30.46.

Ratios:

We take a closer look at IDYA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 17.50 and its Current Ratio is at 17.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

On July 08, 2024, Mizuho started tracking the stock assigning a Outperform rating and target price of $50.

On March 08, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $55.BTIG Research initiated its Buy rating on March 08, 2024, with a $55 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 26 ’24 when Jason Throne bought 75,000 shares for $40.22 per share.

WHITE MICHAEL ANTHONY sold 28,500 shares of IDYA for $1,032,884 on May 29 ’24. The Chief Scientific Officer now owns 0 shares after completing the transaction at $36.24 per share. On May 15 ’24, another insider, Hata Yujiro S, who serves as the President and CEO of the company, sold 83,856 shares for $42.90 each. As a result, the insider received 3,597,756 and left with 677,887 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDYA now has a Market Capitalization of 2580065280 and an Enterprise Value of 1880275840. For the stock, the TTM Price-to-Sale (P/S) ratio is 215.72 while its Price-to-Book (P/B) ratio in mrq is 2.49. Its current Enterprise Value per Revenue stands at 157.201 whereas that against EBITDA is -9.955.

Stock Price History:

Over the past 52 weeks, IDYA has reached a high of $47.74, while it has fallen to a 52-week low of $23.41. The 50-Day Moving Average of the stock is -12.50%, while the 200-Day Moving Average is calculated to be -22.70%.

Shares Statistics:

According to the various share statistics, IDYA traded on average about 695.10K shares per day over the past 3-months and 701920 shares per day over the past 10 days. A total of 84.48M shares are outstanding, with a floating share count of 76.56M. Insiders hold about 9.37% of the company’s shares, while institutions hold 91.78% stake in the company. Shares short for IDYA as of 1727654400 were 12075624 with a Short Ratio of 17.37, compared to 1724976000 on 11421316. Therefore, it implies a Short% of Shares Outstanding of 12075624 and a Short% of Float of 15.98.

Most Popular